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Abstract
IMPORTANCE To our knowledge, no studies have examined light physical activity (PA) measured by
accelerometry and heart disease in older women.
OBJECTIVE To investigate whether higher levels of light PA were associated with reduced risks of
coronary heart disease (CHD) or cardiovascular disease (CVD) in older women.
DESIGN, SETTING, AND PARTICIPANTS Prospective cohort study of older women from baseline
(March 2012 to April 2014) through February 28, 2017, for up to 4.91 years. The setting was
community-dwelling participants from theWomen’s Health Initiative. Participants were ambulatory
womenwith no history of myocardial infarction or stroke.
EXPOSURES Data from accelerometers worn for a requested 7 days were used tomeasure light PA.
MAINOUTCOMESANDMEASURES Cox proportional hazards regressionmodels estimated hazard
ratios (HRs) and 95% CIs for physician-adjudicated CHD and CVD events across light PA quartiles
adjusting for possible confounders. Light PA was also analyzed as a continuous variable with and
without adjustment for moderate to vigorous PA (MVPA).
RESULTS Among 5861 women (mean [SD] age, 78.5 [6.7] years), 143 CHD events and 570 CVD
events were observed. The HRs for CHD in the highest vs lowest quartiles of light PAwere 0.42 (95%
CI, 0.25-0.70; P for trend <.001) adjusted for age and race/ethnicity and 0.58 (95% CI, 0.34-0.99; P
for trend = .004) after additional adjustment for education, current smoking, alcohol consumption,
physical functioning, comorbidity, and self-rated health. Corresponding HRs for CVD in the highest
vs lowest quartiles of light PA were 0.63 (95% CI, 0.49-0.81; P for trend <.001) and 0.78 (95% CI,
0.60-1.00; P for trend = .004). The HRs for a 1-hour/day increment in light PA after additional
adjustment for MVPAwere 0.86 (95% CI, 0.73-1.00; P for trend = .05) for CHD and 0.92 (95% CI,
0.85-0.99; P for trend = .03) for CVD.
CONCLUSIONS ANDRELEVANCE The present findings support the conclusion that all movement
counts for the prevention of CHD and CVD in older women. Large, pragmatic randomized trials are
needed to test whether increasing light PA among older women reduces cardiovascular risk.
JAMA Network Open. 2019;2(3):e190419.
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Key Points
Question Is light physical activity
associated with reduced risk of heart
disease in older women?
Findings In this cohort study of 5861
women, the highest quartile of light
physical activity was associated with a
42% reduced risk of myocardial
infarction or coronary death and a 22%
reduced risk of incident cardiovascular
disease events compared with the
lowest quartile of light physical activity.
These reduced risks persisted after
adjustment for sociodemographic,
behavioral, and health status variables,
as well as moderate to vigorous physical
activity.
Meaning This study suggests that all
daily life physical activity has a role in the
prevention of coronary heart disease
and cardiovascular disease in
older women.
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Introduction
Despite impressive declines in age-standardized coronary heart disease (CHD)mortality rates since
the 1960s, cardiovascular disease (CVD) remains the leading cause of death in the United States and
globally.1 More than half amillion older American individuals die of CVD annually.2 From 1979 to 2011,
declines in CHDmortality among Americans aged 65 to 84 years were faster in older men than
women.3 While prevalence of myocardial infarction (MI) remains higher amongmen than women
across the adult age spectrum, incidence rates of MI or fatal CHD are higher among women 85 years
and older (120 per 1000) than men (85 per 1000).4 Yet, the prevention of CHD in older women is
understudied.
Physical activity (PA) is a key candidate for reducing CHD risk in older women. The long-
standing, prevailing paradigm in PA research is that moderate to vigorous PA (MVPA) for at least 150
minutes per week is needed to prevent CVD in adults. However, ameta-analysis5 of 9 epidemiologic
studies found reduced risks of CHD associated with levels of self-reported MVPA (3 metabolic
equivalent tasks [METs]) that were lower than the recommended guidelines. Light PA at intensity
levels of 1.5 to 3.0METs is poorly measured by self-reported questionnaires because they fail to
capture light movements performed habitually throughout the day.6,7 Recent reports reveal that
light PAmeasured by accelerometry is associated with reduced risks of total8,9 and CVD9mortality,
as well as favorable levels of CVD risk factors.10 To our knowledge, no studies have yet evaluated
whether light PA is associated with reduced risks of incident CHD and CVD in adults overall or in older
women specifically. The objectives of this prospective cohort study were to investigate whether
device-measured light PA was associated with reduced risk of CHD or CVD in a large and diverse
cohort of older women followed from the OPACH baseline (March 2012 to April 2014) and whether
any associations varied by baseline levels of MVPA, estimated CVD risk, or physical functioning.
Methods
Study Participants
The Objectively Measured Physical Activity and Cardiovascular Health (OPACH) study is an ancillary
study to theWomen’s Health Initiative (WHI) that began in the early 1990s to rectify the widespread
lack of data on postmenopausal women and chronic disease. Postmenopausal women aged 50 to
79 years were enrolled in theWHI clinical trials or the observational study from 40 clinical sites
throughout the United States from 1993 to 1998. Between 2012 and 2014, a total of 7058
ambulatory community-dwelling women 63 years and older from theWHI were enrolled in the
OPACH. Details on theWHI and OPACH have been published previously.11-13
Briefly, participants were distributed accelerometers (GT3X+; ActiGraph, LLC) to wear 24 hours
per day on an elastic band over their right hip for a requested 7 days. Participants self-reported in-bed
and out-of-bed times using sleep logs on days when the accelerometer was worn. Of the 6489
womenwhowore accelerometers, 6381 had at least 1 day with 10 or more waking hours of
accelerometer wear. Womenwith anMI or stroke before the OPACH baseline (n = 520) were
excluded, leaving 5861 women (96.1%with4 days with 10 awake hours of accelerometer wear
time) in the analytic study population. The protocol for this study was approved by the Fred
Hutchinson Cancer Research Center Institutional Review Board, and all women provided written
informed consent or telephone informed consent using an institutional review board–approved
script. This report followed the Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE) reporting guidelines for cohort studies.
CHD and CVDOutcomeAscertainment
From the OPACH baseline (March 2012 to April 2014) through February 28, 2017, medical updates
were collected annually by mail or phone. In this report, CHD and CVD events were investigated as
separate outcomes, with CHD identified as the primary end point because of its historically stronger
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associations with self-reported PA. Reports of incident CHD events (MI or coronary death) or incident
CVD events (CHD, revascularization, carotid artery disease, hospitalized angina, congestive heart
failure, stroke, or death from other CVD) were ascertained, and first events of any type were
adjudicated by physician review of medical records (except angina).14 Defining criteria for each
outcome are detailed elsewhere.13 There was excellent agreement among theWHI physicians on
adjudication of CVD outcomes, with values ranging between 0.67 and 0.94 for κ statistics.15 Because
older womenwith a prevalent CVD condition (eg, angina, heart failure, or revascularization) remain
at risk for other incident manifestations of CVD, we examined incident CVD events in the same
population at risk as for the CHD end point (womenwith no history of MI or stroke), without
additional exclusion of other prevalent CVD conditions at baseline. Sensitivity analyses were
conducted to determine if findings were consistent when the baseline population excluded women
with the symptomatic conditions of angina and heart failure at the OPACH baseline.
PAMeasures
Accelerometer data, originally collected at 30 Hz, were aggregated to 15-second epochs using the
normal frequency filter within ActiLife version 6 software (ActiGraph, LLC). Accelerometer nonwear
periods were identified and removed using the Choi algorithm as previously described.13,16 Sleep
time was removed using reported in-bed and out-of-bed times from sleep logs. Missing bed times
were imputed using participant-specific mean times or, if all data were missing, the OPACH
populationmean (10:45 PM for in-bed time and 7:22 AM for out-of-bed time).
Time spent in light PA andMVPAwas computed from accelerometer data using activity
intensity thresholds determined in the OPACH Calibration Study.17 Light PA, movements with energy
expendituremeasured by indirect calorimetry between 1.6 and 2.9METs, was computed as themean
minutes per day of 15-second epochs having vectormagnitude (VM) counts between 19 and 518 per
day.17 TheMVPA (METs3.0) was computed as themeanminutes per day of 15-second epochs with
VM counts of at least 519 per day.17 The PAmeasures were averaged over all days with awake wear
time of at least 10 hours, and all such days were included in this analysis. Light PA and MVPA were
adjusted for awake wear time using the residuals method to account for any systematic variations in
in-bed or nonwear times.18
Covariates
Potential confounders were selected based on previous literature and included age, self-identified
race/ethnicity from questionnaire categories (white, black, or Hispanic/Latina), body mass index
(BMI), highest education (high school or less, some college, or college graduate), current smoking
(yes or no), alcohol consumption (nondrinker, <1 drink per week,1 drink per week, or unknown),
physical functioning (using a 10-item subscale from the RAND 36-ItemHealth Survey 1.0
(RAND-36),19 ranging from0 [low] to 100 [high]), number of non-CVD chronic conditions (none, 1-2,
or3 from the sum of cancer, chronic obstructive pulmonary disease, cognitive impairment,
depression, diabetes, and osteoarthritis), and systolic blood pressure, as well as self-rated health
(excellent or very good; good; fair or poor). Race/ethnicity was assessed in theWHI to allow
investigation of disparities. Fasting serum glucose, insulin, total cholesterol, high-density lipoprotein
cholesterol (HDL-C), and high-sensitivity C-reactive protein (hsCRP) assays were conducted at the
University of Minnesota Fairview Advanced Research and Diagnostic Laboratory, Minneapolis, using
standardized Clinical Laboratory Improvement Act–approvedmethods. The Reynolds Risk Score, a
strong predictor of CVD risk in theWHI cohort,20 was computed as previously described but without
glycated hemoglobin level in womenwith diabetes, which was not available.
Statistical Analysis
Participant characteristics were summarized across quartiles of light PA using means and standard
deviations for continuous variables and percentages for categorical variables. F tests and Pearson χ2
tests assessed differences across quartiles for continuous and categorical variables, respectively.
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Hazard ratios (HRs) for new CHD and CVD events were estimated for quartiles of light PA and
MVPA (with quartile 1 as reference) using Cox proportional hazards regression. Time to event was
computed as the number of days from the OPACH baseline to the date of first occurrence of a CHD or
CVD event, death, or the last medical update. Regressionmodels were progressively adjusted as
follows: model 1 (n = 5861) included age and race/ethnicity; model 2 (n = 5822) added highest
education, current smoking, and alcohol consumption; model 3 (n = 5750) added physical
functioning, comorbidity, and self-rated health; andmodel 4 (n = 5861) added CVD risk factors (BMI,
systolic blood pressure, hsCRP, total cholesterol, and HDL-C) thought to be in the causal pathway
between PA and CVD. Biomarker data were missing from 1226 participants for whom no blood
specimens were available. Therefore, models with biomarkers used data that were imputed by
multivariable chained equations using 100 iterations and including CHD, CVD, both times to event,
light PA, MVPA, and all covariates in the process.21 Model 4 results using complete case analysis are
listed in eTable 1 in the Supplement. P values for linear trend tests were computed from Cox
proportional hazards regressionmodels that contained the continuous functional form of light PA
andMVPA. Tests based on Schoenfeld residuals22 were used to check the proportional hazards
assumptions. No violations were observed.
To examine the dose-response association of light PA (continuous variable) with CHD and CVD,
restricted cubic spline functions23 were added to Cox proportional hazards regressionmodel 3 with
knots placed at the recommended 5th, 50th, and 95th percentiles (results were insensitive to
whether 3 or 4 knots were used [eTable 2 in the Supplement]).24 Linearity of the dose-response
association was checked usingWald tests. Dose-response trajectories were then plotted using the
10th percentile of the light PA distribution (3.3 hours per day) as the referent category.8 To test
whether associations of light PA with CHD and CVD events were independent of MVPA, spline
analyses were repeated adjusted for MVPA.
Stratified analyses were conducted to evaluate the consistency of associations across high and
low levels of baseline estimated CVD risk based on the Reynolds Risk Score (median, 9.2), MVPA
(median, 44.3 minutes per day), and RAND-36 physical function score (median, 75.0) defined using
median splits for each variable. Hazard ratios were computed frommodel 3 for light PA and MVPA
comparing the 75th and 25th percentiles of light PA (difference of 1.60 hours per day) and MVPA
(difference of 42minutes per day) within each strata. The statistical significance of possible effect
modificationwas tested by adding a cross product interaction term tomodel 3. All variables were first
mean centered to reducemulticollinearity.
All data analyses were conducted using statistical software (R, version 3.3.2; R Foundation for
Statistical Computing) with the survival and rms packages. Statistical tests were all 2 sided, with the
level of significance set to .05.
Sensitivity Analyses
Models were also further adjusted for use of lipid-lowering and antihypertensive medications and for
the Healthy Eating Index.25 Because symptoms preceding new CVD events could lead women to
engage in less PA, all models were repeated after excluding CHD and CVD cases that occurred within
the first 6months of follow-up. To test whether the symptomatic conditions (angina and heart
failure) were altering associations between light PA and CVD, we (1) repeatedmodel 3 after excluding
womenwith a history of hospitalized angina or heart failure at the OPACH baseline and (2) repeated
model 3 after excluding hospitalized angina and heart failure from the CVD end point.
Results
Themean (SD) age of 5861 OPACH participants was 78.5 (6.7) years (range, 63-99 years) (Table 1).
One-third (33.5%) of the OPACHwomenwere black, 17.6%were Hispanic, and 48.8%were of white
race/ethnicity. The mean daily time spent in light PA ranged from 0.6 to 10.3 hours per day, with
women in the lowest quartile having less than 3.9 hours per day and women in the highest quartile
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engaging in more than 5.6 hours per day. Greater proportions of younger women and black and
Hispanic/Latina womenwere seen in the higher quartiles of light PA, but there were no differences
by educational attainment. Women with more light PA had lower mean BMI, higher RAND-36
physical function scores, and lower levels of comorbidity (Table 1). As reported previously,10 the
Table 1. Baseline Characteristics by Quartile of Time Spent in Light PA Among 5861Women
Characteristic
No./Total No. (%)a
P ValueQ1 (Low) Q2 Q3 Q4 (High)
No. 1466 1465 1465 1465
Age, mean (SD), y 79.9 (6.7) 78.7 (6.7) 78.1 (6.6) 77.4 (6.5) <.001
Race/ethnicity
White 895 (61.1) 742 (50.6) 655 (44.7) 571 (39.0)
<.001Black 399 (27.2) 490 (33.4) 524 (35.8) 553 (37.7)
Hispanic/Latina 172 (11.7) 233 (15.9) 286 (19.5) 341 (23.3)
BMI, mean (SD) 30.2 (6.2) 28.6 (5.5) 27.5 (5.3) 26.3 (5.1) <.001
Highest education
High school or less 277/1454 (19.1) 287/1455 (19.7) 287/1449 (19.8) 325/1464 (22.2)
.26Some college 581/1454 (40.0) 580/1455 (39.9) 551/1449 (38.0) 535/1464 (36.5)
College graduate 596/1454 (41.0) 588/1455 (40.4) 611/1449 (42.2) 604/1464 (41.3)
Current smoker 48 (3.3) 38 (2.6) 28 (1.9) 27 (1.8) .04
Alcohol consumption
Nondrinker 544 (37.1) 474 (32.4) 480 (32.8) 467 (31.9)
<.001
<1 Drink/wk 471 (32.1) 476 (32.5) 465 (31.7) 433 (29.6)
≥1 Drinks/wk 301 (20.5) 383 (26.1) 404 (27.6) 442 (30.2)
Unknown 150 (10.2) 132 (9.0) 116 (7.9) 123 (8.4)
RAND-36 physical function score, mean (SD) 60.5 (27.7) 68.2 (25.9) 73.7 (23.3) 76.4 (22.4) <.001
No. of chronic conditionsb
None 340 (23.2) 356/1464 (24.3) 376 (25.7) 410 (28.0)
<.0011-2 951 (64.9) 972/1464 (66.4) 963 (65.7) 945 (64.5)
≥3 175 (11.9) 136/1464 (9.3) 126 (8.6) 110 (7.5)
Self-rated health
Excellent or very good 690/1461 (47.2) 727/1458 (49.9) 793/1460 (54.3) 818/1458 (56.1)
<.001Good 596/1461 (40.8) 603/1458 (41.4) 543/1460 (37.2) 536/1458 (36.8)
Fair or poor 175/1461 (12.0) 128/1458 (8.8) 124/1460 (8.5) 104/1458 (7.1)
Uses antihypertensive medication 985 (67.2) 924 (63.1) 908 (62.0) 873 (59.6) <.001
Uses antilipidemic medication 620 (42.3) 641 (43.8) 549 (37.5) 513 (35.0) <.001
Light PA, mean (SD), min/d 196.0 (32.2) 262.2 (14.2) 309.6 (14.0) 379.6 (38.8) <.001
Reynolds Risk Score, mean (SD) 16.2 (13.2) 12.7 (10.3) 11.5 (9.5) 9.6 (8.2) <.001
MVPA, mean (SD), min/d 34.2 (25.8) 47.2 (29.8) 56.5 (33.7) 66.2 (35.7) <.001
Blood pressure, mean (SD), mm Hg
Systolic 127.6 (15.2) 126.0 (13.9) 124.8 (13.8) 124.1 (13.7) <.001
Diastolic 73.5 (9.4) 73.0 (8.5) 72.5 (8.4) 71.6 (8.4) <.001
hsCRP, mean (SD), mg/Lc 0.8 (1.1) 0.7 (1.0) 0.6 (1.0) 0.4 (1.0) <.001
Cholesterol, mean (SD), mg/dL
Total 195.4 (40.0) 198.1 (39.6) 199.9 (39.4) 202.5 (38.1) <.001
HDL 56.6 (13.8) 59.8 (14.1) 62.1 (15.3) 64.1 (15.2) <.001
Abbreviations: BMI, bodymass index (calculated as weight in kilograms divided by
height in meters squared); HDL, high-density lipoprotein; hsCRP, high-sensitivity
C-reactive protein; MVPA, moderate to vigorous PA; PA, physical activity; Q, quartile.
SI conversion factors: To convert cholesterol level to millimoles per liter, multiply by
0.0259; to convert hsCRP level to nanomoles per liter, multiply by 9.524.
a Adjusted for awake wear time using the residuals method. Quartile cut points are 36 to
236min/d for Q1, 237 to 285min/d for Q2, 286 to 333min/d for Q3, and 334 to
617 min/d for Q4. For some variables in the table, totals are less than the column
headings because of missing data.
b Cancer, chronic obstructive pulmonary disease, cognitive impairment, depression,
diabetes, and osteoarthritis.
c Natural log transformed.
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Reynolds Risk Score and levels of blood pressure and CVD biomarkers (glucose, insulin, and lipid
levels) were more favorable among womenwith higher levels of light PA.
A total of 143 incident cases of CHD and 570 incident cases of CVD occurred during 20 718
person-years of follow-up (mean, 3.53 years; range, 0.01-4.91 years) (Table 2). The CHDHR
comparing the highest vs lowest quartiles adjusted for age and race/ethnicity (model 1) was 0.42
(95% CI, 0.25-0.70; P for trend <.001). The HR after model 3 adjustments was 0.58 (95% CI, 0.34-
0.99; P for trend = .004). The HR after further model 4 adjustment for CVD risk factors, including
BMI, systolic blood pressure, hsCRP, total cholesterol, and HDL-C, was 0.68 (95% CI, 0.39-1.18; P for
trend = .03; 42% lower risk of CHD).
Associations between light PA and incident CVD events followed a similar pattern (Table 2). The
CVDHRs comparing the highest vs lowest quartiles were 0.63 (95%CI, 0.49-0.81; P for trend <.001)
after minimal adjustment (model 1), 0.78 (95% CI, 0.60-1.00; P for trend = .004) after adjustment
for confounders (model 3), and 0.82 (95% CI, 0.63-1.07; P for trend = .02; 18% lower risk of CVD)
after inclusion of CVD risk factors likely to be in the causal pathway (model 4).
Table 2. Associations of Incident CHD and CVDWith Light Physical Activity andMVPA in the ObjectivelyMeasured Physical Activity
and Cardiovascular Health (OPACH) Cohort (2012-2017)
Outcome and Modela
HR (95% CI)b
P Value
for TrendcQ1 (Low) Q2 Q3 Q4 (High)
Light PA
Incident CHD events (crude incidence rate
per 1000 person-years)
59 (11.8) 36 (7.0) 28 (5.4) 20 (3.8) NA
Model 1 1 [Reference] 0.67 (0.44-1.01) 0.55 (0.35-0.87) 0.42 (0.25-0.70) <.001
Model 2 1 [Reference] 0.71 (0.47-1.08) 0.60 (0.38-0.96) 0.46 (0.28-0.78) <.001
Model 3 1 [Reference] 0.79 (0.51-1.20) 0.72 (0.45-1.15) 0.58 (0.34-0.99) .004
Model 4 1 [Reference] 0.82 (0.54-1.26) 0.79 (0.49-1.27) 0.68 (0.39-1.18) .03
Incident CVD events (crude incidence rate
per 1000 person-years)
183 (37.9) 161 (32.3) 124 (24.3) 102 (19.7) NA
Model 1 1 [Reference] 0.93 (0.75-1.15) 0.73 (0.58-0.92) 0.63 (0.49-0.81) <.001
Model 2 1 [Reference] 0.96 (0.78-1.19) 0.77 (0.61-0.97) 0.66 (0.52-0.85) <.001
Model 3 1 [Reference] 1.02 (0.82-1.27) 0.88 (0.69-1.11) 0.78 (0.60-1.00) .004
Model 4 1 [Reference] 1.05 (0.84-1.30) 0.90 (0.71-1.14) 0.82 (0.63-1.07) .02
MVPA
Incident CHD events (crude incidence rate
per 1000 person-years)
77 (15.6) 25 (4.9) 24 (4.6) 17 (3.2) NA
Model 1 1 [Reference] 0.38 (0.24-0.61) 0.42 (0.26-0.68) 0.34 (0.19-0.59) <.001
Model 2 1 [Reference] 0.40 (0.25-0.63) 0.44 (0.27-0.71) 0.38 (0.22-0.67) <.001
Model 3 1 [Reference] 0.46 (0.29-0.72) 0.55 (0.34-0.90) 0.54 (0.30-0.96) .001
Model 4 1 [Reference] 0.45 (0.28-0.72) 0.58 (0.36-0.95) 0.58 (0.32-1.04) .003
Incident CVD events (crude incidence rate
per 1000 person-years)
229 (48.7) 143 (28.7) 106 (20.6) 92 (17.5) NA
Model 1 1 [Reference] 0.68 (0.55-0.84) 0.54 (0.42-0.68) 0.50 (0.39-0.65) <.001
Model 2 1 [Reference] 0.69 (0.56-0.86) 0.55 (0.44-0.71) 0.53 (0.41-0.69) <.001
Model 3 1 [Reference] 0.77 (0.62-0.96) 0.65 (0.51-0.84) 0.69 (0.53-0.91) .009
Model 4 1 [Reference] 0.75 (0.61-0.93) 0.66 (0.52-0.84) 0.71 (0.54-0.93) .02
Abbreviations: CHD, coronary heart disease; CVD, cardiovascular disease; HR, hazard
ratio; MVPA, moderate to vigorous physical activity; NA, not applicable; PA, physical
activity; Q, quartile.
a Data used for model 4 were imputed because biomarker data were missing from 1226
women. Results from complete case analysis are listed in eTable 1 in the Supplement.
Regressionmodels were progressively adjusted as follows: model 1 (n = 5861) included
age and race/ethnicity; model 2 (n = 5822) added highest education, current smoking,
and alcohol consumption; model 3 (n = 5750) added physical functioning, comorbidity,
and self-rated health; andmodel 4 (n = 5861) added CVD risk factors (bodymass index,
systolic blood pressure, high-sensitivity C-reactive protein, total cholesterol, and
high-density lipoprotein cholesterol) thought to be in the causal pathway between PA
and CVD.
b Adjusted for awake wear time using the residuals method. Quartile cut points for light
PA are 36 to 236 min/d for Q1, 237 to 285 min/d for Q2, 286 to 333 min/d for Q3, and
334 to 617 min/d for Q4. Quartile cut points for MVPA less than 26 min/d for Q1, 27 to
44min/d for Q2, 45 to 68min/d for Q3, and 69 to 350min/d for Q4.
c P values from Cox proportional hazards regressionmodels that include light PA as a
continuous variable.
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For MVPA, HRs indicated statistically significant risk reductions for both CHD and CVD
beginning at quartile 2, which corresponds to 27minutes or more of MVPA daily, agreeing well with
PA guidelines (Table 2). The HRs comparing the women in the highest vs lowest MVPA quartiles after
adjusting formodel 3 confounderswere 0.54 (95%CI, 0.30-0.96; P for trend = .001; 46% lower risk
of CHD) for CHD and 0.69 (95% CI, 0.53-0.91; P for trend = .009; 31% lower risk of CVD) for CVD.
Analyzing light PA as a continuous variable, the risk for incident CHD and CVD events decreased
in a linear dose-dependent manner over increasing light PA levels (eTable 2 in the Supplement).
Hazard ratios adjusting for potential confounders (model 3) for each 1-hour increment in light PA
were 0.80 (95%CI, 0.69-0.93; P for trend = .004) for CHD (Figure 1A) and0.90 (95%CI, 0.83-0.97;
P for trend = .004) for CVD (Figure 1B). Adjustment for MVPA (model 4) slightly attenuated
associations, with HRs for 1 hour of light PA changing to 0.86 (95% CI, 0.73-1.00; P for trend = .05)
for incident CHD events and to 0.92 (95% CI, 0.85-0.99; P for trend = .03) for incident CVD events.
As shown in Figure 2 comparingwomen in the 75th vs 25th percentiles of light PA, reduced risks
of incident CHD events were observed across high and low levels of Reynolds Risk Score and
RAND-36 physical function score. Hazard ratios for light PA appeared stronger among womenwith
low MVPA, but the interaction was not statistically significant. Similar results were observed in
stratified analyses for incident CVD events. For MVPA, HRs were somewhat stronger than for light PA
for CHD overall (HR for the 75th vs 25th percentiles, 0.59; 95%CI, 0.42-0.81) and in some strata. No
statistically significant interactions were observed betweenMVPA and any of the stratifying factors
(Figure 2). No statistically significant interactions were observed between light PA and race/ethnicity
for either the CHD or CVD outcomes.
Sensitivity analyses indicated that results were unchanged when CHD or CVD events that
occurred during the first 6months of follow-up were excluded or when additional adjustments were
made for use of lipid-lowering medication, antihypertensive medication, and the Healthy Eating
Index. Results were also unchanged when womenwith angina and heart failure at the OPACH
baseline were excluded from the analytic sample and when angina and heart failure were excluded
from the CVD end point.
Discussion
In this prospective cohort study of older women, light PAmeasured by accelerometry was associated
with a dose-responsive, independent reduced risk of incident CHD and CVD events. The highest
quartile of light PA was associated with a 42% reduced risk of MI or coronary death and a 22%
reduced risk of incident CVD events compared with the lowest quartile of light PA. These reduced
risks persisted after multivariable adjustment that included physical functioning and other measures
of health status, even though some covariates may themselves be altered by PA and thus dilute the
associations. The reduced risks of CHD and CVD were also statistically significant after simultaneous
adjustment for MVPA. In this study, intensity of PA was classified using a triaxial accelerometer VM
count cut point specifically calibrated in a clinic-based study17 for older women. To our knowledge,
this is the first study to investigate accelerometer-measured light PA in relation to incident CHD,
including nonfatal and fatal events in older women.
Themajority of active time in older adults is spent in light PA, which contributes about equally
to daily PA energy expenditure as MVPA in older people.26 Yet, little is known about the
cardiovascular consequences of light PA. Previous studies5 on the dose response between PA and
CHD risk have focused on amounts of self-reportedMVPA, not on the entire range of PA intensity
that could be associated with benefit. A major barrier has been that self-reported questionnaires
measuring leisure-time PA do not adequately capture light PA that is acquired throughout the day in
activities of daily living. In the OPACH cohort, there was essentially no correlation between light PA
measured by the WHI physical activity questionnaire27,28 and by accelerometry (r = 0.03).29 In a
recent analysis of National Health and Nutrition Examination Survey data,8 US adults 40 years and
older who spent 5 or more hours per day in accelerometer-measured light PA had a 23% lower risk of
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mortality compared with those who spent less than 3 hours per day in light PA (HR, 0.77; 95% CI,
0.60-1.00). However, other reports found no association of accelerometer-measured light PA with
total or CVD mortality.30,31 By contrast, the OPACH women in the highest vs lowest tertiles of low
light PA (19-225 VM counts per 15 seconds) had a 36% reduction in risk of CVDmortality (95% CI,
0.41-0.99) after adjustments similar to those of the present study, and women in the highest tertile
of high light PA (226-518 VM counts per 15 seconds) had a 70% reduced risk of CVD mortality (95%
CI, 0.17-0.51).9 The inconsistencies among these previous resultsmay be due to differences in study
Figure 1. ContinuousDose-ResponseAssociationofLightPhysicalActivity (PA)WithCoronaryHeartDisease (CHD)
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A, Association with incident CHD events. B,
Association with incident CVD events. C, Distribution
of daily light PA for the Objectively Measured Physical
Activity and Cardiovascular Health (OPACH) cohort.
All associations were estimated using multivariable
linear Cox proportional hazards regressionmodels
adjusted for age, race/ethnicity, highest education,
current smoking, alcohol consumption, physical
functioning, comorbidity, and self-rated health (blue
lines). Orange lines show results after additional
adjustment for moderate to vigorous PA (MVPA). The
reference category was set to the 10th percentile of
light PA (3.3 hours per day). Respective hazard ratios
(HRs) and 95% CIs for 4, 5, and 6 hours per day of light
PA (compared with the reference) were for CHD: not
adjusted for MVPA 0.84 (0.75-0.95), 0.68
(0.52-0.88), 0.54 (0.36-0.82); adjusted for MVPA
0.89 (0.79-1.00), 0.76 (0.58-1.00), 0.65 (0.42-1.01).
For CVD: not adjusted forMVPA0.92 (0.87-0.97), 0.83
(0.73-0.94), 0.74 (0.61-0.91); adjusted forMVPA0.94
(0.88-1.00), 0.86 (0.75-0.99), 0.79 (0.64-0.98).
Results were trimmed at the 1st and 99th percentiles.
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populations, length of follow-up, cut points used to classify PA intensity, approaches to adjustment,
and statistical power, as well as whether or not early events and deaths were excluded to account for
reverse causality. The strong, independent associations of light PAwith reduced risks of incident CHD
and CVD in the present study add notably to this growing evidence base because both fatal and
nonfatal incident CVD events were studied.
Associations of light PA with incident CHD are biologically plausible. In the OPACH cohort,
womenwho engaged in greater light PA hadmore favorable baseline levels of HDL-C and low-density
lipoprotein cholesterol, triglycerides, glucose, CRP, BMI, and Reynolds Risk Score.20 Adjustment for
CVD risk factors attenuated associations between light PA and first CHD or CVD events, supporting
the possibility that light PA alters CHD risk partially, but not completely, through its association with
these risk factors. Accelerometer-measured light PA has also been associated with lower levels of
subclinical atherosclerosis, including carotid femoral pulse wave velocity and carotid intimamedia
thickness in older men.32
The present findings are consistent with a large body of evidence showing that self-reported
MVPA reduces risk of CHD and CVD in the United States and worldwide.5,33 In the OPACH cohort,
women in the highest quartile of MVPA had a 46% reduced risk of incident CHD and a 31% reduced
Figure 2. Associations of Physical Activity (PA)With Coronary Heart Disease (CHD) and Cardiovascular Disease (CVD) Events, by Selected Participant Characteristics
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A, Associations comparing the 75th vs 25th percentiles of light PA (difference of 1.6 hours
per day) with incident CHD and CVD events. B, Associations comparing the 75th vs 25th
quartiles of moderate to vigorous PA (MVPA) (difference of 42minutes per day) with
incident CHD and CVD events. Hazard ratios (HR) were adjusted for age, race/ethnicity,
highest education, current smoking, alcohol consumption, physical functioning,
comorbidity, and self-rated health (where appropriate). Reynolds Risk Score, MVPA,
physical functioning, and light PAwere split at themedian. Hazard ratios below 1 indicate
favorable associations (ie, lower risk), whereas those above 1 indicate harmful
associations (ie, higher risk). NA indicates not applicable; error bars, 95% CIs. The n
values for subanalyses stratified by Reynolds Risk Score do not sum to 5750 because of
missing biomarker data.
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risk of CVD events compared with their less active peers in the lowest quartile (Table 2). For light PA,
the same comparisons yielded risk reductions of 42% and 22% for CHD and CVD, respectively. The
magnitude of these associations for light PA and their consistency across strata of CVD risk, physical
functioning, andMVPA suggest that light PA could havemuch to offer older women in the prevention
of CVDwhether or not they can or choose to engage in MVPA.
Strengths and Limitations
This prospective study had numerous strengths, including the large, diverse cohort of women.
Substantial representation of women older than 80 years provides evidence in an understudied but
increasingly numerous segment of the US population. Inclusion of fatal and nonfatal physician-
adjudicated CHD and CVD end points is a major strength. Use of accelerometers with calibrated
age-appropriate cut points for distinguishing light PA fromMVPA is a major and unique strength of
this study. Resting metabolic rate declines with age,34 and the energy costs of activity increase with
age.35,36 The OPACH Calibration Study17 showed that the typically used National Health and Nutrition
Examination Survey cut points37 result in underestimation of bothMVPA and light PA. Wewere not
able to examine relative intensity, which requires individual calibrationwithmaximal exercise testing.
For somewomen, a MET value of 1.5 to 3.0 could fall within themoderate range of PA intensity. The
study had up to 5 years of follow-up and was conducted only among older women. However, our
results appear generalizable to men given a recent study38 of 1181 older British men that reported an
HR for light PA of 0.74 (95%CI, 0.41-1.34) for incident CVD events, which is remarkably similar to the
HR of 0.78 (95% CI, 0.60-1.00) in the present study. Longer-term prospective studies with inclusion
of both sexes are needed to increase the strength of the evidence base on light PA in relation to CVD
prevention.
Conclusions
In 2016, an estimated 25% of US women 75 years and older met federal PA guidelines for aerobic
activity,39 which require 75minutes of vigorous activity or 150minutes of moderate activity per
week. These guidelines may have discouraged PAwhen perceived to be unattainable by large
segments of the population. The present findings support the newly released 2018 Physical Activity
Guidelines Advisory Committee Scientific Report, which states that “[f]or individuals who perform
no or little moderate-to-vigorous physical activity, replacing sedentary behavior with light-intensity
physical activity reduces the risk of all-cause mortality, cardiovascular disease incidence and
mortality”40(pA-4) and suggests that “all movement counts” when it comes to CHD and CVD
prevention in older women. Large randomized trials, such as the ongoingWomen’s Health Initiative
Strong and Healthy Study (WHISH41), are needed to conclusively determine whether pragmatic
interventions can increase light PA among older women and whether doing so reduces the
occurrence of CVD. Given the low risks of light PA and the abundance of light movements that are
part of everyday life, even in the absence of definitive trial data, it may be prudent to encourage older
women to increase light PA to improve their CVD health and reduce the occurrence of CVD events.
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